Phase 2 Trial to Assess Revatio in Premature Infants With BPD at Risk of PH
Researchers have designed a Phase 2 clinical trial to test the safety and preliminary effectiveness of Revatio (sildenafil) in preventing pulmonary hypertension (PH) in premature infants with severe bronchopulmonary dysplasia (BPD). An overview of the study, “Safety of sildenafil…